Buscar

Mostrando ítems 41-50 de 76

Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases

2020- Rafael-Vidal, C.; Pérez Gómez, Nair; Altabás, I.; Garcia, S.; Pego Reigosa, José María

Value of Serum NEUROG1 Methylation for the Detection of Advanced Adenomas and Colorectal Cancer

2020- Otero-Estévez, O.; Gallardo-Gomez, M.; Cadena, M. P.; Rodríguez-Berrocal, F. J.; Cubiella Fernández, Joaquín; [et al.]

Transbronchial biopsy results according to diffuse interstitial lung disease classification. Cryobiopsy versus forceps: MULTICRIO study

2020- Pajares, V.; Nuñez Delgado, Manuel; Bonet, G.; Pérez-Pallarés, J.; Martínez, R.; [et al.]

Proposal of a clinical care pathway for quality and safe management of headache patients: a consensus study report

2020- Pascual, J.; Pozo-Rosich, P.; Carrillo, I.; Rodríguez Justo, Sandra; Jiménez-Hernández, D.; [et al.]

Percutaneous treatment with Mitraclip for functional mitral regurgitation: medium-term follow up according to left ventricular function

2020- Pascual, I.; Benito-Gonzalez, T.; Hernandez-Vaquero, D.; Estevez Loureiro, Rodrigo; Lorca, R.; [et al.]

Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design

2020- Núñez-Gil, I. J.; Estrada, V.; Fernández-Pérez, C.; Feltes, G.; Vedia, O.; [et al.]

BR-BCSC Signature: The Cancer Stem Cell Profile Enriched in Brain Metastases that Predicts a Worse Prognosis in Lymph Node-Positive Breast Cancer

2020- Dionisio, M. R.; Vieira, A. F.; Carvalho, R.; Conde, I.; Oliveira, M.; [et al.]

Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations

2020- Martín-Nalda, A.; Fortuny, C.; Rey Cordo, Carmen Lourdes; Bunney, T. D.; Alsina, L.; [et al.]

Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial

2020- Curran, A.; Rull, A.; Navarro, J.; Vidal-González, J.; Martin-Castillo, M.; [et al.]

New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The "Time-Within-Remission Range

2020- de Hollanda, A.; Lecube, A.; Rubio, M. A.; Sanchez, E.; Vilarrasa, N.; [et al.]

1
. . .
2
3
4
5
6
7
8